ARROGENE, INC

Profile

Company Names

ARROGENE, INC
SRKP 16 INC

Addresses

12100 WILSHIRE BLVD., STE. 800, LOS ANGELES, CA 90025

8560 W. SUNSET BLVD, #400, LOS ANGELES, CA 90069

8560 W. SUNSET BLVD, #424, LOS ANGELES, CA 90069

2500 BROADWAY, SUILDING F, SUITE F-125, SANTA MONICA, CA 90404

2500 BROADWAY,, BLDG. F, SUITE F-125, SANTA MONICA, CA 90404

2500 BROADWAY, SUITE F-125, SANTA MONICA, CA 90045

2500 BROADWAY, BUILDING F, # F-125, SANTA MONICA, CA 90045

5777 W. CENTURY BLVD, SUITE 360B, LOS ANGELES, CA 90045

5777 WEST CENTURY BLVD, SUITE 360B, LOS ANGELES, CA 90045

5777 W CENTURY BLVD, SUITE 360B, LOS ANGELES, CA 90045

Phone Numbers

424-274-4791
310 203 2902
424-238-4442

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$7,215,223.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-10-28 
$10,000.00 
$990,000.00 
$980,000.00 
Equity 
6
2018-04-30 
$524,863.00 
$1,000,000.00 
$475,137.00 
Equity 
5
2018-03-02 
$2,708,110.00 
$2,755,458.00 
$47,348.00 
Equity 
4
2016-02-21 
$750,000.00 
$5,000,000.00 
$4,250,000.00 
Debt 
3
2014-12-30 
$250,000.00 
$1,000,000.00 
$750,000.00 
Debt 
2
2014-02-28 
$700,000.00 
$700,000.00 
$0.00 
Debt 
1
2012-01-11 
$2,272,250.00 
$4,800,000.00 
$2,527,750.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LARRY 
A. 
COUTURE 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
HOSCH 
DIRECTOR
JACK 
 
KAVANAUGH 
EXECUTIVE OFFICER, DIRECTOR
JULIA 
 
LJUBIMOVA 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
 
SPERBER 
EXECUTIVE OFFICER
ROBERT 
 
STUCKELMAN 
DIRECTOR
RANDOLPHE 
 
SWENSON 
DIRECTOR
MAURIZIO 
 
VECCHIONE 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2019-10-28 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2018-03-02 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2016-02-21 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2014-12-30 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2014-02-28 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2014-02-28 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Debt 
2014-02-28 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D/A
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
D
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2012-01-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GVC CAPITAL LLC
NONE
NONE
WESTPARK CAPITAL INC.
NONE
NONE
WESTPARK CAPITAL
NONE
NONE
GVC CAPITAL
WESTPARK CAPITAL
GVC CAPITAL LLC
WESTPARK CAPITAL
GVC CAPITAL LLC